[go: up one dir, main page]

MA25223A1 - Procede pour la preparation de 4-carboxy-amino-2-substitue-1,2,3,4 tetrahydroquinoleine - Google Patents

Procede pour la preparation de 4-carboxy-amino-2-substitue-1,2,3,4 tetrahydroquinoleine

Info

Publication number
MA25223A1
MA25223A1 MA26112A MA26112A MA25223A1 MA 25223 A1 MA25223 A1 MA 25223A1 MA 26112 A MA26112 A MA 26112A MA 26112 A MA26112 A MA 26112A MA 25223 A1 MA25223 A1 MA 25223A1
Authority
MA
Morocco
Prior art keywords
tetrahydroquinoleine
substitue
carboxy
amino
preparation
Prior art date
Application number
MA26112A
Other languages
English (en)
Inventor
Wayne Dugger Robert
Burns Damon David
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of MA25223A1 publication Critical patent/MA25223A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/42—Nitrogen atoms attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Quinoline Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MA26112A 1999-11-30 2000-11-29 Procede pour la preparation de 4-carboxy-amino-2-substitue-1,2,3,4 tetrahydroquinoleine MA25223A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16796799P 1999-11-30 1999-11-30

Publications (1)

Publication Number Publication Date
MA25223A1 true MA25223A1 (fr) 2001-07-02

Family

ID=22609556

Family Applications (1)

Application Number Title Priority Date Filing Date
MA26112A MA25223A1 (fr) 1999-11-30 2000-11-29 Procede pour la preparation de 4-carboxy-amino-2-substitue-1,2,3,4 tetrahydroquinoleine

Country Status (44)

Country Link
US (1) US6313142B1 (fr)
EP (1) EP1125929B1 (fr)
JP (1) JP3579345B2 (fr)
KR (1) KR100408177B1 (fr)
CN (1) CN1173953C (fr)
AP (1) AP2000002011A0 (fr)
AR (1) AR029775A1 (fr)
AT (1) ATE315028T1 (fr)
AU (1) AU784694B2 (fr)
BG (1) BG105009A (fr)
BR (1) BR0005636A (fr)
CA (1) CA2327029C (fr)
CO (1) CO5261552A1 (fr)
CY (1) CY1104989T1 (fr)
CZ (1) CZ20004407A3 (fr)
DE (1) DE60025317T2 (fr)
DK (1) DK1125929T3 (fr)
DZ (1) DZ3079A1 (fr)
EA (1) EA003668B1 (fr)
EE (1) EE200000659A (fr)
ES (1) ES2254109T3 (fr)
GE (1) GEP20022798B (fr)
GT (1) GT200000190A (fr)
HN (1) HN2000000203A (fr)
HR (1) HRP20000804A2 (fr)
HU (1) HUP0004747A3 (fr)
ID (1) ID28489A (fr)
IL (1) IL139849A (fr)
IS (1) IS5715A (fr)
MA (1) MA25223A1 (fr)
NO (1) NO20006039L (fr)
NZ (1) NZ508509A (fr)
OA (1) OA11494A (fr)
PA (1) PA8503801A1 (fr)
PE (1) PE20010913A1 (fr)
PL (1) PL344208A1 (fr)
SG (1) SG102603A1 (fr)
SK (1) SK17792000A3 (fr)
TN (1) TNSN00230A1 (fr)
TW (1) TW591016B (fr)
UA (1) UA65615C2 (fr)
UY (1) UY26451A1 (fr)
YU (1) YU71500A (fr)
ZA (1) ZA200006947B (fr)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HN2000000203A (es) * 1999-11-30 2001-06-13 Pfizer Prod Inc Procedimiento para la obtencion de 1,2,3,4-tetrahidroquinolinas 4-carboxiamino-2- sustituidas.
RU2004121898A (ru) * 2001-12-19 2006-01-20 Атеродженикс, Инк. (Us) Производные халкона и их применение для лечения заболеваний
US7202247B2 (en) 2001-12-19 2007-04-10 Atherogenics, Inc. 1,3-bis-(substituted-phenyl)-2-propyn-1-ones and their use to treat disorders
DE60323954D1 (de) * 2002-04-11 2008-11-20 Roar Holding Llc Ex-vivo-verfahren zur bestimmung der cetp-aktivität und der wirksamkeit der behandlung von herzerkrankungen
US7504508B2 (en) * 2002-10-04 2009-03-17 Millennium Pharmaceuticals, Inc. PGD2 receptor antagonists for the treatment of inflammatory diseases
US20090181966A1 (en) * 2002-10-04 2009-07-16 Millennium Pharmaceuticals, Inc. PGD2 receptor antagonists for the treatment of inflammatory diseases
KR20050055747A (ko) * 2002-10-04 2005-06-13 밀레니엄 파머슈티컬스 인코퍼레이티드 염증 질환 치료용의 ｐｇｄ2 수용체 길항제
US7223870B2 (en) 2002-11-01 2007-05-29 Pfizer Inc. Methods for preparing N-arylated oxazolidinones via a copper catalyzed cross coupling reaction
WO2004056727A2 (fr) * 2002-12-19 2004-07-08 Atherogenics, Inc. Procede de fabrication de derives de chalcone
US20040132771A1 (en) * 2002-12-20 2004-07-08 Pfizer Inc Compositions of choleseteryl ester transfer protein inhibitors and HMG-CoA reductase inhibitors
EP1578415B1 (fr) 2002-12-20 2008-09-10 Pfizer Products Inc. Formes posologiques comprenant un inhibiteur de cetp et un inhibiteur de hmg-coa reductase
WO2004078730A2 (fr) * 2003-03-04 2004-09-16 Takasago International Corporation Procede de production d'amines optiquement actives
US7276536B2 (en) * 2003-03-17 2007-10-02 Japan Tobacco Inc. Method for increasing the bioavailability of the active form of S-[2-([[1-(2-ethylbutyl)cyclohexyl]carbonyl]amino) phenyl] 2-methylpropanethioate
ATE534381T1 (de) * 2003-03-17 2011-12-15 Japan Tobacco Inc Pharmazeutische cetp-inhibitor-zusammensetzungen
TWI494102B (zh) * 2003-05-02 2015-08-01 Japan Tobacco Inc 包含ｓ-〔２（〔〔１-（２-乙基丁基）環己基〕羰基〕胺基）苯基〕２-甲基丙烷硫酯及ｈｍｇ輔酶ａ還原酶抑制劑之組合
US7749992B2 (en) * 2003-10-08 2010-07-06 Eli Lilly And Company Compounds and methods for treating dislipidemia
UA90269C2 (ru) * 2004-04-02 2010-04-26 Мицубиси Танабе Фарма Корпорейшн Тетрагидрохинолиновые производные и способ их получения
KR20070041452A (ko) * 2004-06-24 2007-04-18 일라이 릴리 앤드 캄파니 이상지혈증 치료를 위한 화합물 및 방법
DOP2005000123A (es) 2004-07-02 2011-07-15 Merck Sharp & Dohme Inhibidores de cetp
WO2006033001A1 (fr) * 2004-09-23 2006-03-30 Pfizer Products Inc. Composes de quinoline
US7700774B2 (en) * 2004-12-20 2010-04-20 Dr. Reddy's Laboratories Ltd. Heterocyclic compounds and their pharmaceutical compositions
RU2007135224A (ru) * 2005-02-24 2009-03-27 Милленниум Фармасьютикалз, Инк. (Us) Антагонисты рецептора pgd2 для лечения воспалительных заболеваний
TW200808731A (en) 2006-03-30 2008-02-16 Tanabe Seiyaku Co A process for preparing tetrahydroquinoline derivatives
CL2008000684A1 (es) 2007-03-09 2008-08-01 Indigene Pharmaceuticals Inc Composicion farmaceutica que comprende metformina r-(+) lipoato y un inhibidor de reductasa hmg-coa; formulacion de dosis unitaria; y uso en el tratamiento de una complicacion diabetica.
CN101429160B (zh) * 2007-11-06 2011-10-19 上海药明康德新药开发有限公司 一种1-r-4-氨基-1,2,3,4-四氢喹啉的合成方法
AR077208A1 (es) 2009-06-30 2011-08-10 Lilly Co Eli Derivados del acido trans-4-[[(5s)-5-[[[3,5-bis(trifluorometil) fenil] metil] (2-metil-2h-tetrazol-5-il) amino) -2,3,4,5-tetrahidro-7,9-dimetil-1h-1-benzazepin-1-il) metil)-ciclohexancarboxilico y sus formas cristalinas, composiciones farmaceuticas que los comprenden, su uso para preparar un medicam
AU2023303916A1 (en) 2022-07-05 2025-01-30 Newamsterdam Pharma B.V. Salts of obicetrapib and processes for their manufacture and intermediates thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR7870M (fr) * 1968-11-08 1970-04-27
US3971789A (en) 1972-10-21 1976-07-27 John Wyeth & Brother Limited O-(4-Quinolylamino)benzamides
GB8432091D0 (en) 1984-12-19 1985-01-30 Wyeth John & Brother Ltd 4-aminoquinoline derivatives
US4839368A (en) 1986-05-02 1989-06-13 Mochida Pharmaceutical Co., Ltd. 1-acyl-2,3-dihydro-4(1H)-quinolinone-4-oxime derivatives
GB8804444D0 (en) 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
US5231102A (en) 1989-03-08 1993-07-27 Merck Sharp & Dohme, Ltd. Tetrahydroquinoline derivatives useful for neurodegenerative disorders
PT100905A (pt) * 1991-09-30 1994-02-28 Eisai Co Ltd Compostos heterociclicos azotados biciclicos contendo aneis de benzeno, ciclo-hexano ou piridina e de pirimidina, piridina ou imidazol substituidos e composicoes farmaceuticas que os contem
US6140342A (en) 1998-09-17 2000-10-31 Pfizer Inc. Oxy substituted 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinolines
US6197786B1 (en) * 1998-09-17 2001-03-06 Pfizer Inc 4-Carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines
US6147089A (en) 1998-09-17 2000-11-14 Pfizer Inc. Annulated 4-carboxyamino-2-methyl-1,2,3,4,-tetrahydroquinolines
HN2000000203A (es) * 1999-11-30 2001-06-13 Pfizer Prod Inc Procedimiento para la obtencion de 1,2,3,4-tetrahidroquinolinas 4-carboxiamino-2- sustituidas.

Also Published As

Publication number Publication date
ID28489A (id) 2001-05-31
YU71500A (sh) 2003-02-28
JP3579345B2 (ja) 2004-10-20
JP2001163859A (ja) 2001-06-19
DZ3079A1 (fr) 2004-10-24
BG105009A (en) 2001-11-30
AR029775A1 (es) 2003-07-16
GT200000190A (es) 2002-04-27
EP1125929B1 (fr) 2006-01-04
TW591016B (en) 2004-06-11
EA003668B1 (ru) 2003-08-28
PL344208A1 (en) 2001-06-04
NO20006039L (no) 2001-05-31
AU784694B2 (en) 2006-06-01
PE20010913A1 (es) 2001-09-10
EA200001129A3 (ru) 2001-10-22
BR0005636A (pt) 2001-07-17
UY26451A1 (es) 2001-06-29
AP2000002011A0 (en) 2000-12-31
CO5261552A1 (es) 2003-03-31
TNSN00230A1 (fr) 2005-11-10
UA65615C2 (uk) 2004-04-15
SG102603A1 (en) 2004-03-26
HU0004747D0 (fr) 2001-02-28
NZ508509A (en) 2001-06-29
CY1104989T1 (el) 2010-03-03
ES2254109T3 (es) 2006-06-16
IS5715A (is) 2001-05-31
GEP20022798B (en) 2002-09-25
HK1038007A1 (en) 2002-03-01
SK17792000A3 (sk) 2002-10-08
PA8503801A1 (es) 2002-07-30
KR20010052012A (ko) 2001-06-25
CA2327029C (fr) 2005-08-09
CN1173953C (zh) 2004-11-03
AU7178900A (en) 2001-05-31
CZ20004407A3 (cs) 2002-06-12
EE200000659A (et) 2001-08-15
DE60025317T2 (de) 2006-08-03
KR100408177B1 (ko) 2003-12-01
EA200001129A2 (ru) 2001-06-25
IL139849A0 (en) 2002-02-10
HUP0004747A2 (hu) 2001-10-28
ATE315028T1 (de) 2006-02-15
HUP0004747A3 (en) 2002-12-28
OA11494A (en) 2004-05-07
ZA200006947B (en) 2002-05-27
HN2000000203A (es) 2001-06-13
US6313142B1 (en) 2001-11-06
DK1125929T3 (da) 2006-04-03
NO20006039D0 (no) 2000-11-29
HRP20000804A2 (en) 2001-06-30
DE60025317D1 (de) 2006-03-30
CA2327029A1 (fr) 2001-05-30
EP1125929A1 (fr) 2001-08-22
IL139849A (en) 2006-10-31
CN1302800A (zh) 2001-07-11

Similar Documents

Publication Publication Date Title
MA25223A1 (fr) Procede pour la preparation de 4-carboxy-amino-2-substitue-1,2,3,4 tetrahydroquinoleine
FR2740132B1 (fr) Procede pour la preparation de 1,1,1,3,3-pentafluoropropane
MA25984A1 (fr) Procede pour preparation de maleate d'amlodipine.
MA23143A1 (fr) Procede pour la preparation de compositions vaccinantes .
MA25493A1 (fr) Derives de 3(5)-amino-pyrazole, procede pour leur preparation et leur utilisation en tant qu'agents antitumoraux.
MA24182A1 (fr) Procede pour la preparation de 2,4-diaminopyrimidines substituees
FR2785609B1 (fr) Procede de preparation de la methionine
FR2781801B1 (fr) Procede pour la preparation de dianhydride pyromellique
EP1023250A4 (fr) Procede de preparation de 2,6-dialkylnaphtalene
FR2818979B1 (fr) Procede de preparation d'imidaclopride
FR2773558B1 (fr) Procede pour l'obtention de 1-butene
IL139023A0 (en) Process for the preparation of 2,3,5-trimethyl-p- benzoquinone
FR2733227B1 (fr) Procede pour la preparation de 1,1-difluoroethane
FR2768725B1 (fr) Procede de preparation du 2-chloroprop-1-ene
EP1565448A4 (fr) Procede de preparation de 10h-dibenzo b,f 1,4 thiazepin-11-one
FR2791669B1 (fr) Procede de preparation du fluoroformiate de tertiobutyle
EP1295864A4 (fr) Procede de preparation de 1,5-diaminonaphtalenes
MA24464A1 (fr) Procede de preparation de composes nouveaux .
FR2800376B1 (fr) Procede pour la production d'alkylhalogenosilanes
MA24015A1 (fr) Procede pour la preparation de dioxo-azabicyclohexanes
FR2805535B1 (fr) Nouveau procede de preparation de l'isoindoline
FR2796963B1 (fr) Procede d'obtention de lignees isotransgeniques
FR2731703B1 (fr) Procede pour la preparation de difluoromethane
FR2750998B1 (fr) Procede de preparation de k-carraghenase
FR2776999B3 (fr) Procede pour la preparation de 2-chloro-1-cyclohexyl-4- ethynylbenzene